XML 62 R27.htm IDEA: XBRL DOCUMENT v3.19.3
Share-Based Payment Awards (Tables)
9 Months Ended
Sep. 30, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock Option Activity Under Plan

The following table provides a reconciliation of stock option activity under the Company’s equity incentive plans and for inducement awards for the nine months ended September 30, 2019:

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

Remaining

 

 

Aggregate

 

 

 

Number

 

 

Exercise

 

 

Contractual

 

 

Intrinsic

 

 

 

of Options

 

 

Price

 

 

Life

 

 

Value

 

 

 

 

 

 

 

 

 

 

 

(in years)

 

 

(in thousands)

 

Outstanding at January 1, 2019

 

 

8,139,377

 

 

$

2.83

 

 

 

 

 

 

 

 

 

Granted

 

 

4,474,096

 

 

 

2.36

 

 

 

 

 

 

 

 

 

Exercised

 

 

(166,760

)

 

 

1.84

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(1,361,109

)

 

 

2.49

 

 

 

 

 

 

 

 

 

Expired

 

 

(473,346

)

 

 

3.77

 

 

 

 

 

 

 

 

 

Outstanding at September 30, 2019

 

 

10,612,258

 

 

$

2.65

 

 

 

7.69

 

 

$

289

 

Exercisable at September 30, 2019

 

 

4,957,932

 

 

$

3.07

 

 

 

6.11

 

 

$

41

 

Schedule of Key Assumptions Used

In determining the grant date fair value of option awards during the nine months ended September 30, 2019, the Company applied the Black-Scholes option pricing model based on the following key assumptions:

 

Option life (in years)

 

5.50 - 6.08

 

Stock volatility

 

60% - 64%

 

Risk-free interest rate

 

1.29% - 2.63%

 

Expected dividends

 

0.0%

 

Summary of Information about Stock Options

The following table summarizes information about employee, non-executive director and external consultant stock options for the nine months ended September 30, 2019 (in thousands, except per share amount):

 

 

 

Nine Months

Ended

 

 

 

September 30, 2019

 

Weighted-average grant date fair value per share

 

$

0.95

 

Total cash received from exercise of stock options

 

 

308

 

Total intrinsic value of stock options exercised

 

 

63

 

Summary of Restricted Stock Unit Activity

The following table provides a reconciliation of RSU activity under the 2016 Plan for the nine months ended September 30, 2019:

 

 

 

 

 

 

 

Weighted

 

 

 

Number of

 

 

Average

 

 

 

Restricted

 

 

Grant Date

 

 

 

Stock Units

 

 

Fair Value

 

Nonvested at January 1, 2019

 

 

590,213

 

 

$

1.86

 

Granted

 

 

587,761

 

 

 

1.90

 

Vested

 

 

(229,294

)

 

 

1.81

 

Forfeited

 

 

(136,333

)

 

 

2.18

 

Nonvested at September 30, 2019

 

 

812,347

 

 

$

1.85

 

Summary of Performance Stock Unit Activity

The following table provides a reconciliation of PSU activity for the nine months ended September 30, 2019:

 

 

 

 

 

 

 

Weighted

 

 

 

Number of

 

 

Average

 

 

 

Performance

 

 

Grant Date

 

 

 

Stock Units

 

 

Fair Value

 

Nonvested at January 1, 2019

 

 

370,000

 

 

$

2.01

 

Vested

 

 

(58,334

)

 

 

1.56

 

Forfeited

 

 

(255,000

)

 

 

2.26

 

Nonvested at September 30, 2019

 

 

56,666

 

 

$

1.34

 

Summary of Deferred Stock Unit Activity

 

 

 

 

 

 

Weighted

 

 

 

Number of

 

 

Average

 

 

 

Deferred

 

 

Grant Date

 

 

 

Stock Units

 

 

Fair Value

 

Nonvested at January 1, 2019

 

 

35,418

 

 

$

1.95

 

Vested

 

 

(35,418

)

 

 

1.95

 

Nonvested at September 30, 2019

 

 

 

 

$

 

 

Compensation Expense from Stock-Based Payment Awards

The Company’s consolidated statements of comprehensive loss included total compensation expense from stock-based payment awards for the three and nine months ended September 30, 2019 and 2018, respectively, as follows (in thousands):

 

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended

September 30,

 

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Compensation expense included in:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

$

210

 

 

$

486

 

 

$

874

 

 

$

1,145

 

Sales and marketing

 

 

189

 

 

 

263

 

 

 

512

 

 

 

314

 

General and administrative

 

 

578

 

 

 

648

 

 

 

2,325

 

 

 

1,355

 

 

 

$

977

 

 

$

1,397

 

 

$

3,711

 

 

$

2,814